Oct 29, 2014 8:05pm EDT Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
Sep 08, 2014 11:00am EDT Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference
Sep 04, 2014 8:51pm EDT Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN
Jun 17, 2014 11:30am EDT Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
Mar 11, 2014 12:00pm EDT Recro Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares